P/L responsibility for a leading supplier of sterile-grade die-cut lid, roll stock, and pouch products to the medical device and pharmaceutical markets.

Led global team of direct and matrix-managed resources expanding market presence in forensic analysis of DNA, expected to be a $2B+ market by 2020.

Managed Strategic planning and budgeting processes for $300MM division of life sciences business acquired in 2007. Led process to analyze diverse business (>6,000 SKUs), resulting in simplified strategy focused on Lab Productivity, Human Identification & Diagnostic Components.Secured approval for $20MM+ investment for exclusive global distribution rights to technology to transform GE presence in DNA analysis market.

P&L accountability for global business unit generating $190 MM revenue and $70MM profit. Direct responsibility for a cross-functional team in a biotechnology services business, including business strategy, product development and operations improvement.• Grew top line 10%+ with margin expansion in a challenging business environment• Team reduced inventory 15% by implementing a variety of controls and measurements• Oversaw negotiation of partnership agreements that generated $12MM+ in new business

Managed an international team responsible for marketing strategy and tactics for a $100 million+ biotechnology services business.- Worked with executive management team to devise and implement a strategy that resulted in 18% CAGR 2005 – 2008. - Served as Services lead for integration of a $400MM business acquired in 2006. - Negotiated terms related to Services business with manufacturers entering into distribution agreements with GE Healthcare.

Manage an in house service organization of 70 people responsible content generation and delivery in a 24 x 7 deadline driven environment. · Managed $11 million operating budget. Reduced annual operating costs by $2 million (18%) as a result of process improvement and digitization projects.

Applied Six-Sigma methodology to production operations as a part of General Electric’s Six-Sigma program. Led major change initiatives and productivity programs and mentored employees leading small-scope Six-Sigma projects.

Reviewed operating procedures at $1B+ pharmaceutical companies and identified regulatory compliance risks and operational inefficiencies. Devised mitigation strategies and corrective action plans to address deficiencies.

Responsible for sales and support of computerized data acquisition and analysis systems for the life and physical sciences. Areas of emphasis included pharmacology, cardiology and neurophysiology. Increased sales in territory nearly 200% in 3 year tenure.